KRTAP22-2
gene geneOn this page
Also known as KAP22.2
Summary
KRTAP22-2 (keratin associated protein 22-2, HGNC:37091) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 22-2 (Q3LI68). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in intermediate filament.
Source: NCBI Gene 100288287 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 7 total — 1 pathogenic
- MANE Select transcript:
NM_001164434
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37091 |
| Approved symbol | KRTAP22-2 |
| Name | keratin associated protein 22-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP22.2 |
| Ensembl gene | ENSG00000206106 |
| Ensembl biotype | protein_coding |
| Entrez | 100288287 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382830
RefSeq mRNA: 1 — MANE Select: NM_001164434
NM_001164434
CCDS: CCDS46641
Canonical transcript exons
ENST00000382830 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001493474 | 30590105 | 30590397 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 75.38.
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.38 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| corpus callosum | UBERON:0002336 | 29.82 | silver quality |
| monocyte | CL:0000576 | 29.57 | gold quality |
| leukocyte | CL:0000738 | 29.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| blood | UBERON:0000178 | 25.65 | gold quality |
| muscle of leg | UBERON:0001383 | 24.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting KRTAP22-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-4284 | 99.36 | 65.25 | 1293 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-6732-3P | 98.17 | 67.52 | 802 |
| HSA-MIR-7112-3P | 97.67 | 68.77 | 948 |
| HSA-MIR-125B-2-3P | 96.69 | 68.38 | 1210 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 22-2 — Q3LI68 (reviewed: Q3LI68)
All UniProt accessions (1): Q3LI68
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 20 family.
RefSeq proteins (1): NP_001157906* (*=MANE)
Domains & families (InterPro)
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI68-F1 | 39.61 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, HMGA1_TARGET_GENES, MIR513B_5P, MIR4671_3P, MIR7112_3P, MIR6732_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): intermediate filament (GO:0005882)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
16 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP22-2 | KRTAP6-2 | Q3LI66 | 0 |
| KRTAP22-2 | KRTAP19-7 | Q3SYF9 | 0 |
| KRTAP22-2 | LCE3B | Q5TA77 | 0 |
| KRTAP22-2 | KRTAP20-1 | Q3LI63 | 0 |
| KRTAP22-2 | KRTAP20-3 | Q3LI60 | 0 |
| KRTAP22-2 | KRTAP20-4 | Q3LI62 | 0 |
| KRTAP22-2 | KRTAP21-3 | Q3LHN1 | 0 |
| KRTAP22-2 | KRTAP19-6 | Q3LI70 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3062431 | GRCh37/hg19 21q11.2-22.3(chr21:15023401-48097372)x3 | Pathogenic |
SpliceAI
95 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30590270:T:TA | donor_gain | 0.9500 |
| 21:30590205:A:AC | donor_gain | 0.8100 |
| 21:30590327:G:C | donor_gain | 0.8100 |
| 21:30590249:T:A | donor_gain | 0.7300 |
| 21:30590346:C:CT | donor_gain | 0.7200 |
| 21:30590347:T:TT | donor_gain | 0.7200 |
| 21:30590182:AAC:A | donor_gain | 0.6600 |
| 21:30590345:G:C | donor_gain | 0.6400 |
| 21:30590351:A:T | donor_gain | 0.6100 |
| 21:30590342:CAGG:C | donor_gain | 0.6000 |
| 21:30590204:CA:C | donor_gain | 0.5900 |
| 21:30590341:CCAGG:C | donor_gain | 0.5900 |
| 21:30590224:A:C | donor_gain | 0.5800 |
| 21:30590223:A:AC | donor_gain | 0.5700 |
| 21:30590271:C:A | donor_gain | 0.5700 |
| 21:30590306:GTTAC:G | donor_loss | 0.5600 |
| 21:30590307:TTA:T | donor_loss | 0.5600 |
| 21:30590308:TACC:T | donor_loss | 0.5600 |
| 21:30590309:ACCAT:A | donor_loss | 0.5600 |
| 21:30590310:C:T | donor_loss | 0.5600 |
| 21:30590305:AGTT:A | donor_loss | 0.5500 |
| 21:30590311:C:G | donor_loss | 0.5500 |
| 21:30590314:A:AC | donor_gain | 0.5400 |
| 21:30590343:AGGC:A | donor_gain | 0.5200 |
| 21:30590118:TGACC:T | acceptor_loss | 0.4800 |
| 21:30590121:CCTG:C | acceptor_loss | 0.4800 |
| 21:30590245:T:TA | donor_gain | 0.4800 |
| 21:30590123:T:A | acceptor_loss | 0.4700 |
| 21:30590304:GAGTT:G | donor_loss | 0.4700 |
| 21:30590299:AT:A | donor_gain | 0.4600 |
AlphaMissense
287 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30590240:G:C | F45L | 0.926 |
| 21:30590240:G:T | F45L | 0.926 |
| 21:30590242:A:G | F45L | 0.926 |
| 21:30590264:G:C | F37L | 0.883 |
| 21:30590264:G:T | F37L | 0.883 |
| 21:30590266:A:G | F37L | 0.883 |
| 21:30590285:A:C | F30L | 0.835 |
| 21:30590285:A:T | F30L | 0.835 |
| 21:30590287:A:G | F30L | 0.835 |
| 21:30590241:A:G | F45S | 0.760 |
| 21:30590291:G:C | C28W | 0.657 |
| 21:30590286:A:C | F30C | 0.656 |
| 21:30590241:A:C | F45C | 0.641 |
| 21:30590293:A:G | C28R | 0.616 |
| 21:30590357:G:C | N6K | 0.614 |
| 21:30590357:G:T | N6K | 0.614 |
| 21:30590265:A:G | F37S | 0.587 |
| 21:30590286:A:G | F30S | 0.578 |
| 21:30590345:G:C | S10R | 0.576 |
| 21:30590345:G:T | S10R | 0.576 |
| 21:30590347:T:G | S10R | 0.576 |
| 21:30590358:T:A | N6I | 0.569 |
dbSNP variants (sampled 300 via entrez): RS1000996787 (21:30591383 T>C), RS1001292211 (21:30590687 G>A), RS1002849561 (21:30591770 T>C), RS1002962558 (21:30592062 CTAAT>C), RS1004299521 (21:30592303 G>A), RS1004551143 (21:30590948 T>C), RS1004640084 (21:30589958 A>G), RS1005032494 (21:30590266 A>G), RS1006296614 (21:30591664 AT>A), RS1006720106 (21:30591394 T>C), RS1008034151 (21:30590738 T>G), RS1008566601 (21:30591120 A>G), RS1009109561 (21:30589677 T>G), RS1011898286 (21:30590713 T>A), RS1012023853 (21:30591039 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.